
    
      This study is designed in order to assess the efficacy of the investigational product
      (Progesterone acqueous s.c. formulation) when it is administered at the dose of 25 and 50 mg.
      The induced predecidual changes will be evaluated through endometrial bioptic samplings,
      performed on day 11 and will be compared between the two treatment groups.

      The pharmacokinetic evaluation was designed according to internationally recognised
      guidelines for PK studies.
    
  